window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 24, 2026

  • News
  • About Us
Contact Us

Infectious Diseases

  • Clinical Development,Clinical Trials,Drug Development,Infectious Diseases,Pharmaceuticals and therapeutics,Precision medicine,Supply Chain & Logistics

    Gilead reports positive Phase 3 results for single-tablet HIV regimen

    Gilead Sciences has announced positive topline results from the Phase [...]

    November 13, 2025
  • Biologics & Biosimilars,Clinical Development,Clinical Trials,Drug approval,Infectious Diseases,Pharmaceuticals and therapeutics,Regulatory Affairs,RNA Therapeutics

    Cidara Therapeutics receives FDA Breakthrough Therapy designation for CD388 in seasonal influenza prevention

    Cidara Therapeutics has received Breakthrough Therapy designation from the US [...]

    October 10, 2025
  • Genomics and sequencing,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    September 9, 2025
  • Biologics & Biosimilars,Drug Development,European biotech,Partnerships & Funding,Precision medicine,Technology and platforms

    Kling Bio and Sanofi collaborate to accelerate discovery of next-generation antiviral antibodies

    Biotech company Kling Bio has announced a new collaboration with [...]

    July 24, 2025
  • Market Access & Commercialization,Precision medicine

    Faster equine respiratory disease testing with bioMérieux’s new Vetfire PCR panel

    With Vetfire, bioMérieux enters the veterinary PCR market with an [...]

    June 4, 2025
  • Clinical Trials

    Cefiderocol shows improved outcomes when used earlier in treatment pathway, new European data reveals

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study
    Categories: Uncategorised
  • Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions
    Categories: Biologics & Biosimilars, Drug Delivery & Formulation, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
  • NeuroVice seizure oral injury device now available through BlinkRx
    Categories: Central Nervous System, Digital Health, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top